Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/10/09 16:36:08」(JST)

wiki en

Keratan sulfate (KS), also called keratosulfate, is any of several sulfated glycosaminoglycans (structural carbohydrates) that have been found especially in the cornea, cartilage, and bone. It is also synthesized in the central nervous system where it participates both in development^[1] and in the glial scar formation following an injury.^[2] Keratan sulfates are large, highly hydrated molecules which in joints can act as a cushion to absorb mechanical shock.

Keratan sulfate structure

Like other glycosaminoglycans keratan sulfate is a linear polymer that consists of a repeating disaccharide unit. Keratan sulfate occurs as a proteoglycan (PG) in which KS chains are attached to cell-surface or extracellular matrix proteins, termed core proteins. KS core proteins include Lumican, Keratocan, Mimecan, Fibromodulin, PRELP, Osteoadherin and Aggrecan.

The basic repeating disaccharide unit within keratan sulfate is -3Galβ1-4GlcNAcβ1-. This can be sulfated at carbon position 6 (C6) of either or both the Gal or GlcNAc monosaccharides. However, the detailed primary structure of specific KS types are best considered to be composed of three regions:^[3]

A linkage region, at one end of which the KS chain is linked to the core protein.
A repeat region, composed of the -3Galβ1-4GlcNAcβ1- repeating disaccharide unit and
A chain capping region, occurring at the opposite end of the KS chain to the protein linkage region.

The monosaccharide mannose is found within the linkage region of keratan sulfate type I (KSI). Disaccharides within the repeating region of KSII may be fucosylated and N-Acetylneuraminic acid caps the end of all keratan sulfate type II (KSII) chains and up to 70% of KSI type chains.^[4]

KS classes

The designations KSI and KSII were originally assigned on the basis of the tissue type from which the keratan sulfate was isolated. KSI was isolated from corneal tissue and KSII from skeletal tissue.^[5]^[6] Minor monosaccharide compositional differences exist between KS extracted from both sources and even KS extracted from the same source. However, major differences occur in the way each KS type is joined to its core protein.^[7] The designations KSI and KSII are now based upon these protein linkage differences. KSI is N-linked to specific asparagine amino acids via N-acetylglucosamine and KSII is O-linked to specific Serine or Threonine amino acids via N-acetyl galactosamine.^[8] The tissue based classification of KS no longer exists as KS types have been shown to be non tissue specific.^[4] A third type of KS (KSIII) has also been isolated from brain tissue that is O-linked to specific serine or threonine amino acids via mannose.^[9]

Corneal KSI

The amount of KS found in the cornea is 10 fold higher than it is in cartilage and 2-4 times higher than it is in other tissues.^[10] It is produced by corneal keratocytes ^[11] and is thought to play a role of a dynamic buffer of corneal hydration. In a rare progressive disorder called macular corneal dystrophy (MCDC), the synthesis of keratan sulfate is either absent (MCDC type I) or abnormal (MCDC type II).^[12]

Non-corneal KSI

Osteoadherin, Fibromodulin and PRELP are core proteins found in bone and cartilage, that are modified by N-linked KS chains. Osteoadherin and Fibromodulin linked KS chains are shorter than those found in the cornea, typically 8-9 disaccharide units in length.^[13] Whereas corneal KSI is composed of a number of domains showing variable degrees of sulphation the longest of which may be 8-32 disaccharide units in length. The non-reducing terminal of Fibromodulin KS is more similar in structure to the non-reducing terminal of a KSII type keratan sulphate rather than to corneal KSI. KS structure is therefore believed to be determined by the tissue specific availability of glycosyltransferases rather than linkage type to the core protein.^[4]

KSII

Cartilage KSII is almost entirely sulphated, consisting of disulphated monomers interrupted occasionally by a single monosulphated lactosamine monomer.^[8] Fucosylation is also common with alpha-linked fucose present at the carbon 3 position of sulphated GlcNAc, except in the case of tracheal KSII where this feature is absent.

KSIII

References

^ Miller B, Sheppard AM, Pearlman AL (April 1997). "Developmental expression of keratan sulfate-like immunoreactivity distinguishes thalamic nuclei and cortical domains". J. Comp. Neurol. 380 (4): 533–52. doi:10.1002/(SICI)1096-9861(19970421)380:4<533::AID-CNE9>3.0.CO;2-2. PMID 9087531.
^ Zhang H, Uchimura K, Kadomatsu K (November 2006). "Brain keratan sulfate and glial scar formation". Ann. N. Y. Acad. Sci. 1086: 81–90. Bibcode:2006NYASA1086...81Z. doi:10.1196/annals.1377.014. PMID 17185507.
^ Tai GH, Huckerby TN and Nieduszynski IA. (1996). "Multiple non-reducing chain termini isolated from bovine corneal keratan sulfates" (PDF). J. Biol. Chem. 271 (38): 23535–23546. doi:10.1074/jbc.271.38.23535. PMID 8798563.
^ ^a ^b ^c Funderburgh JL. (2000). "Keratan sulfate: structure, biosynthesis, and function". Glycobiology 10 (10): 951–958. doi:10.1093/glycob/10.10.951. PMID 11030741.
^ Meyer K, Linker A, et al. (1 December 1953). "The mucopolysaccharides of bovine cornea". J. Biol. Chem. 205 (2): 611–616. PMID 13129238.
^ Meyer K, Hoffman P. and Linker A. (1958). "Mucopolysaccharides of Costal Cartilage". Science 128 (3329): 896. Bibcode:1958Sci...128..896M. doi:10.1126/science.128.3329.896. PMID 13592269.
^ Seno N, Meyer K, et al. (1 March 1965). "Variations in Keratosulfates". J. Biol. Chem. 240 (3): 1005–1019. PMID 14284693.
^ ^a ^b Nieduszynski IA, Huckerby TN, et al. (1990). "There are two major types of skeletal keratan sulphates". Biochem. J. 271 (1): 243–245. PMC 1149539. PMID 2222415.
^ Krusius T, Finne J, et al. (25 June 1986). "Identification of an O-glycosidic mannose-linked sialylated tetrasaccharide and keratan sulfate oligosaccharides in the chondroitin sulfate proteoglycan of brain". J. Biol. Chem. 261 (18): 8237–8242. PMID 2941416.
^ Funderburgh JL, Caterson B. and Conrad GW. (1987). "Distribution of proteoglycans antigenically related to corneal keratan sulfate proteoglycan". J. Biol. Chem. 262 (24): 11634–11640. PMID 2957372.
^ Funderburgh JL, Mann MM, Funderburgh ML (November 2003). "Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis". J. Biol. Chem. 278 (46): 45629–37. doi:10.1074/jbc.M303292200. PMC 2877919. PMID 12933807.
^ Macular dystrophy, corneal, 1 - OMIM
^ Lauder RM, Huckerby TN, Nieduszynski IA. (1997). "The structure of the keratan sulphate chains attached to fibromodulin from human articular cartilage". Glycoconj J. 14 (5): 651–660. PMID 9298700.

External links

Chondroitin_and_keratin_sulfate at the Duke University Health System's Orthopedics program
Keratan sulfate at the US National Library of Medicine Medical Subject Headings (MeSH)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ムコ多糖症：臨床的特徴および診断 mucopolysaccharidoses clinical features and diagnosis
2. 成人におけるS状結腸鏡検査および大腸内視鏡検査のための前処置 bowel preparation for colonoscopy and flexible sigmoidoscopy in adults
3. 関節リウマチの病因 pathogenesis of rheumatoid arthritis
4. デヒドロエピアンドロステロンおよびその硫酸塩 dehydroepiandrosterone and its sulfate
5. 子癇前症：管理および予後 preeclampsia management and prognosis

English Journal

[Morquio disease (Mucopolysaccharidosis type IV-A): clinical aspects, diagnosis and new treatment with enzyme replacement therapy].

Politei J1, Schenone AB1, Guelbert N2, Fainboim A3, Szlago M1.
Archivos argentinos de pediatría.Arch Argent Pediatr.2015 Aug 1;113(4):359-64. doi: 10.1590/S0325-00752015000400014.
Mucopolysaccharidosis type IV-A (Morquio A disease) is an autosomal recessive lysosomal storage disease caused by mutations in the gene encoding the N-acetylgalactosamine-6-sulfate sulfatase, that results in impaired catabolism of two glycosaminoglycans, chondroitin-6-sulfate and keratan sulfate. Cl
PMID 26172013

Recombinant, truncated B. circulans keratanase-II: Description and characterisation of a novel enzyme for use in measuring urinary keratan sulphate levels via LC-MS/MS in Morquio A syndrome.

Steward M1, Berezovskaya Y2, Zhou H2, Shediac R2, Sun C3, Miller N2, Rendle PM4.
Clinical biochemistry.Clin Biochem.2015 Aug;48(12):796-802. doi: 10.1016/j.clinbiochem.2015.03.024. Epub 2015 Apr 10.
OBJECTIVE: Morquio A syndrome (mucopolysaccharidosis IVA; MPS IVA) is an autosomal recessive lysosomal storage disorder caused by deficient N-acetylgalactosamine-6-sulphatase (GALNS) activity. Early and accurate diagnosis of this condition is critical for improved patient outcomes, particularly as e
PMID 25866399

Enzyme Replacement Therapies and Immunogenicity in Lysosomal Storage Diseases: Is There a Pattern?

Harmatz P1.
Clinical therapeutics.Clin Ther.2015 Aug 1. pii: S0149-2918(15)00858-9. doi: 10.1016/j.clinthera.2015.06.004. [Epub ahead of print]
Lysosomal storage diseases arise because of genetic mutations that result in nonfunctioning or dysfunctional lysosomal enzymes responsible for breaking down molecules such as glycosaminoglycans or glycogen. Many of these storage diseases, such as the mucopolysaccharidosis (MPS) disorders and Pompe d
PMID 26243075

Japanese Journal

G1-G2 Aggrecan Product that can be Generated by M-calpain on Truncation at Ala^<709>-Ala^<710> is Present Abundantly in Human Articular Cartilage

Maehara Hideaki,Suzuki Kiichi,Sasaki Tomohiro [他],OSHITA Hidefumi,WADA Eriko,INOUE Toshiyuki,SHIMIZU Katsuji
The journal of biochemistry 141(4), 469-477, 2007-04-01
NAID 10020099887

Use of graphitised carbon negative ion LC-MS to analyse enzymatically digested glycosaminoglycans

KARLSSON Niclas G.,SCHULZ Benjamin L.,PACKER Nicolle H.,WHITELOCK John M.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 824(1), 139-147, 2005-09-25
NAID 10017124010

Ultrastructural and immunohistochemical studies of medullary bone calcification, with special reference to sulphated glycosaminoglycans

YAMAMOTO Toshio,NAGAOKA Noriyuki,HIRATA Azumi,NAKAMURA Hiroaki,INOUE Miho,KAWAI Mariko,IKEGAME Mika
Journal of electron microscopy 54(1), 29-34, 2005-01-01
NAID 10015519863